←Back to Expert Scholars
Translational Medicine / 转化医学Colorectal Cancer, Liver Metastases
Thomas Gruenberger
MD
🏢Clinic Favoriten, Vienna🌐Austria
Professor of Surgery, Chief of HPB Surgery
68
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Thomas Gruenberger led pioneering trials of bevacizumab with FOLFOX in perioperative CRLM therapy including the OPEN-BELIEVE studies. He contributed to ALPPS and two-stage hepatectomy methodology and leads European consensus efforts on CRLM management. His work advanced biologics-integrated CRLM care.
Share:
🧪Research Fields 研究领域
bevacizumab CRLM
perioperative chemotherapy
colorectal liver metastases resection
liver regeneration
ALPPS procedure
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Thomas Gruenberger 的研究动态
Follow Thomas Gruenberger's research updates
留下邮箱，当我们发布与 Thomas Gruenberger（Clinic Favoriten, Vienna）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment